首页> 外国专利> METHOD FOR SELECTING TACTICS OF ADMINISTRATION OF PATIENTS WITH PROLACTIN-SECRETING PITUITARY ADENOMA RESISTANT TO CONSERVATIVE TREATMENT BASED ON ANALYSIS OF INDIVIDUAL SPECIFICITIES OF CABERGOLINE PHARMACODYNAMICS

METHOD FOR SELECTING TACTICS OF ADMINISTRATION OF PATIENTS WITH PROLACTIN-SECRETING PITUITARY ADENOMA RESISTANT TO CONSERVATIVE TREATMENT BASED ON ANALYSIS OF INDIVIDUAL SPECIFICITIES OF CABERGOLINE PHARMACODYNAMICS

机译:基于Caboboline药动学个体特异性分析的泌乳素分泌性垂体瘤抗保守治疗的患者选择治疗策略的方法

摘要

FIELD: medicine.;SUBSTANCE: using the reversed-phase high-performance liquid chromatography method with detection on a quadrupole tandem mass spectrometer with ionization in electrospray in the positive ion scan mode, after taking the drug at a dose of 0.5 mg, the cabergoline concentration in the patient's blood plasma is determined. With an increase in drug concentration after taking in 240 minutes, the need to continue conservative cabergoline therapy is identified. In the absence of cabergoline concentration growth dynamics in blood, alternative methods of treatment are used.;EFFECT: invention allows to form a personalized approach to the treatment of patients with partially resistant prolactin-secreting adenomas of the pituitary gland, to identify candidate patients as soon as possible to perform operative treatment, to avoid the development of complications due to ineffective therapy.;2 dwg, 2 ex
机译:领域:药物;物质:使用反相高效液相色谱法,在四极串联质谱仪上以正离子扫描模式在电喷雾中进行电离检测,以0.5 mg的剂量服用卡麦角林确定患者血浆中的浓度。服用240分钟后,随着药物浓度的增加,确定了继续进行保守的卡麦角林治疗的必要性。在没有卡麦角林浓度在血液中动态增长的情况下,可以使用其他治疗方法。效果:本发明允许形成一种个性化的方法来治疗垂体泌乳素分泌部分耐药的患者,从而确定候选患者为尽快进行手术治疗,以免因无效治疗而引起并发症。; 2 dwg,2 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号